Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,272 total articles
Bitdeer Technologies Group announced an agreement with Data Center Installations AS (DCI) to finalize the development of the Tydal Data Center facility in Norway, transforming it into an AI data center tailored for co-location of Nvidia Vera Rubin AI technology. The project will deliver 180 MW installed capacity and is expected to be completed by D…
Red Cat Holdings, Inc., a U.S.-based defense technology firm, announced a strategic partnership with Ukraine's state-owned defense enterprise Spetstechnoexport (STE) to accelerate development and deployment of advanced unmanned aerial, land, and maritime systems. The partnership aims to integrate technologies, expand production, and facilitate glob…
Verizon Communications Inc. will report its first-quarter 2026 earnings on April 27, 2026. The company will host a webcast to present its financial results, with detailed materials available on its Investor Relations website ahead of the event.
Old National Bancorp announced that its banking arm, Old National Bank, earned the highest 'Outstanding' overall rating under the Community Reinvestment Act (CRA), recognizing its exceptional commitment to community development lending, investments, and services across multiple states. This rare accolade highlights the bank's strong focus on afford…
iQIYI, a leading Chinese online entertainment video provider listed on Nasdaq, announced plans for a proposed listing on the Hong Kong Stock Exchange to expand capital access and investor base in Asia. The company also approved a $100 million share repurchase program to demonstrate confidence in its long-term prospects. Additionally, iQIYI launched…
CBAK Energy Technology, a NASDAQ-listed Chinese lithium-ion battery manufacturer, reported robust Q4 2025 revenue growth driven by significant increases in light electric vehicle battery sales and battery raw materials amidst a strategic capacity expansion and product portfolio upgrade. The company experienced margin compression and operating losse…
Auddia Inc. announced that LT350, a business unit soon to be merged under the McCarthy Finney holding company via Auddia's pending deal with Thramann Holdings, published a whitepaper introducing a novel distributed AI data center architecture. LT350's platform utilizes modular solar-powered canopies installed on existing parking lots to create powe…
Compass Diversified (NYSE: CODI) announced a definitive agreement to sell the food service business of its subsidiary Sterno to Archer Foodservice Partners for $292.5 million. The sale enables CODI to repay debt and reduce its senior secured net leverage ratio to below 1.0x, improving financial flexibility. Post-sale, CODI will retain the Sterno ho…
Equinox Gold Corp. has updated its technical outlook for its Canadian operations, forecasting an average annual gold production of approximately 540,000 ounces over the next 10 years. Key drivers include reaching full milling capacity at the Greenstone Gold Mine with an average production of 320,000 ounces per year, and the Phase 2 expansion at the…
Sysco Corporation is acquiring Jetro Restaurant Depot in a transformative $29.1 billion transaction. The acquisition expands Sysco's presence into the growing, higher-margin cash & carry segment serving smaller independent restaurants. The deal is expected to be immediately accretive to earnings, deliver significant synergies, and create growth opp…
Roma Green Finance Limited, a Nasdaq-listed provider of ESG and sustainability solutions, has authorized a $100 million share repurchase program effective immediately through December 31, 2028. The company may repurchase shares via open market, block trades, or other legal means depending on market conditions, aiming to fund repurchases from existi…
Sports Entertainment Gaming Global Corporation (SEGG Media) announced the appointment of key executives from Veloce to strengthen its leadership team, emphasizing a strategic growth phase focused on revenue execution, operational integration, and monetization of digital media assets. The company aims to expand revenue streams through its global spo…
Neumora Therapeutics announced their Q4 and full-year 2025 financial results alongside key clinical progress updates. Highlights include positive Phase 1b data reinforcing NMRA-511's potential in Alzheimer's disease agitation, full enrollment of KOASTAL-2 and -3 studies with expected data readout in Q2 2026, advancement of NMRA-898 for schizophreni…
Royalty Pharma announced a $500 million co-funding collaboration with Johnson & Johnson over 2026-2027 to develop JNJ-4804, a novel co-antibody therapy targeting chronic immune-mediated diseases by blocking IL-23 and TNF pathways. This partnership builds on Royalty Pharma's strong immunology investment track record and leverages J&J's leadership in…
Sight Sciences announced that the U.S. District Court for the District of Delaware upheld a jury verdict finding Alcon willfully infringed three of Sight Sciences' patents related to glaucoma treatment devices. The Court awarded Sight Sciences $34 million in past damages plus supplemental damages and interest, and granted an ongoing 10% royalty on …
PMGC Holdings Inc. (NASDAQ: ELAB) filed its 2025 Annual Report highlighting a 43% growth in total assets to $12.87 million, driven by three strategic acquisitions in precision manufacturing and specialty IT hardware packaging serving aerospace, defense, and semiconductor sectors. The company also advanced its biopharmaceutical subsidiary, Northstri…
Connect Biopharma announced a $20.2 million private placement financing led by existing investor Panacea Venture, extending its cash runway through the second half of 2027. The funds will support the development of its clinical-stage drug candidates targeting inflammatory diseases such as asthma and COPD, particularly the next-generation antibody r…
Connect Biopharma announced promising Phase 3 clinical trial results of its drug rademikibart for moderate-to-severe atopic dermatitis. The 52-week study demonstrated rapid, durable efficacy with a high percentage of patients achieving significant skin clearance and an excellent safety profile comparable to placebo. The data were presented at the 2…
Aquestive Therapeutics announced successful completion of a Type A meeting with the FDA regarding the resubmission of the New Drug Application (NDA) for Anaphylm (dibutepinephrine) sublingual film, reaffirming plans to resubmit in Q3 2026. The FDA provided clarifying feedback on pharmacokinetic and human factor study designs, and the company is pre…
Smart Share Global Limited, a Nasdaq-listed consumer tech company providing mobile device charging services in China, has been granted an exception by Nasdaq staff regarding the late filing of its interim financial report for the half-year ended June 30, 2025. The company must file the report by June 29, 2026 to maintain compliance with Nasdaq list…
Terrestrial Energy announced its Q4 and full year 2025 results highlighting selection by Texas A&M for commercial IMSR plant deployment, NRC acceptance of principal design criteria, DOE awards for reactor and fuel pilot projects, and a successful business combination raising $292 million. The company strengthened its position in the US energy marke…
Digital Realty announced the final close of its first U.S. hyperscale data center fund, securing $3.25 billion from institutional investors to own and develop major hyperscale data centers across key U.S. metro areas. The company will manage the fund with a 20% stake and has added two senior executives to strengthen its private capital platform, ai…
PDS Biotechnology Corporation reported financial results for 2025 and updated on clinical progress, including a Phase 3 trial amendment for PDS0101 that incorporates progression-free survival as an interim primary endpoint, potentially shortening trial duration and costs while preserving overall survival as the full approval endpoint. Early promisi…
Connect Biopharma announced positive topline results from its Phase 1 clinical study of intravenous rademikibart, a next-generation anti-IL-4Rα antibody, demonstrating rapid and sustained lung function improvements in asthma and COPD patients. The drug produced clinically meaningful FEV1 increases as early as 15 minutes after dosing and was well to…
Seer, Inc. announced that the U.S. Patent and Trademark Office's Patent Trial and Appeal Board upheld 23 claims of its crucial patent for nano- and microparticle protein enrichment technology used in its Proteograph platform. The decision affirms the intellectual property strength of Seer's proprietary proteomic analysis methods, securing its compe…
